Breast cancer is good for about a third of all new female cancers in the US every year An experimental treatment by Pfizer and Arvinas delayed the progression of breast cancer with more than three months compared to AstraZeneca’s Faslodex in patients with a specific gene mutation, according to the results of the test announced […]
